세계의 맞춤형 정신의학 시장 : 제품 유형별, 치료 분야별, 최종 사용자별, 기술별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 및 예측(2024-2032년)

REPORT HIGHLIGHT

Personalized Psychiatry Market size was valued at USD 4,209.43 million in 2023, expanding at a CAGR of 11.98% from 2024 to 2032.

The growing incidence of conditions like depression, anxiety, bipolar disorder, and schizophrenia necessitates more effective and personalized treatment methods. Increasing understanding of the genetic basis of psychiatric disorders is enabling more personalized treatment approaches. The development and implementation of personalized treatment plans can be expensive, limiting accessibility for some patients. International efforts to address the global mental health crisis can support the development and dissemination of personalized psychiatry approaches.

Personalized Psychiatry Market- Market Dynamics

Rising Prevalence of Mental Health Disorders

The growing incidence of mental health disorders is significantly propelling the personalized psychiatry market. Personalized psychiatry, which tailors treatment plans to the individual characteristics of each patient, is gaining traction as a response to the complex and varied nature of mental health conditions. The rising number of individuals diagnosed with mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia is a primary driver. The World Health Organization (WHO) reports that depression is a leading cause of disability worldwide, affecting over 264 million people. The growing recognition of mental health issues and the destigmatization of seeking help are contributing to higher diagnosis rates. The rise of digital health platforms and mobile health applications is facilitating personalized care by providing continuous monitoring and real-time data collection.

Personalized Psychiatry Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.98% over the forecast period (2024-2032)

Based on product type segmentation, Genomics was predicted to show maximum market share in the year 2023

Based on therapeutic areas segmentation, Depression and Anxiety was the leading type in 2023

Based on end users segmentation, Healthcare Providers was the leading type in 2023

based on region, North America was the leading revenue generator in 2023

Personalized Psychiatry Market- Segmentation Analysis:

The Global Personalized Psychiatry Market is segmented based on Product Type, therapeutic areas, End-user, Technology, and Region.

The market is divided into three categories based on product type: Genomics, Digital Therapeutics, and Software. Due to the rise in the use of digital devices in the healthcare sector, the genomics category holds the largest market share in 2023, while the digital therapeutics segment is predicted to develop at the quickest rate in the upcoming years. Thanks to developments in genomic technologies, it is now possible to identify genetic differences linked to psychiatric diseases, which opens the door to customized treatment plans.

The market is divided into five categories based on therapeutic areas: Depression, Anxiety, Bipolar Disorders, Addiction, and Others. In 2023, the market for depression and anxiety is expected to reach a sizeable amount, and in the ensuing years, it is expected to grow even faster. the expanding understanding of the variability among various illnesses, with different underlying causes and treatment outcomes for different people. This understanding has increased the need for individualized methods of diagnosis and therapy.

Personalized Psychiatry Market- Geographical Insights

The need for individualized psychiatric interventions is being driven by the increasing prevalence of mental health issues in North America. Furthermore, the area has excellent research and healthcare infrastructure, which supports the creation and uptake of personalized medicine strategies. Furthermore, strong investments in healthcare innovation and regulations and initiatives from the government encourage the expansion of the personalized psychiatry market in North America. The personalized psychiatry market is anticipated to grow at the quickest rate in the Asia-Pacific area. This rise is driven by elements including expanding investments in healthcare technology, raising awareness of mental health issues, and developing healthcare infrastructure.

Personalized Psychiatry Market- Competitive Landscape:

Major pharmaceutical companies are increasingly investing in personalized psychiatry. They are developing tailored medications based on genetic and biomarker information. Companies like Johnson & Johnson, Pfizer, and Roche are prominent in this space. Biotechnology companies are at the forefront of developing innovative diagnostic tools and therapies. They often focus on niche areas and leverage cutting-edge technologies. Examples include Myriad Genetics, Genomind, and Assurex Health. There is a growing trend of collaborations between pharmaceutical companies, biotech firms, academic institutions, and technology providers. These partnerships are essential for advancing research and bringing new personalized therapies to market. For instance, in May 2024, Osmind, the foremost psychiatric handling and investigate platform, publicized a ground-breaking partnership with the American Psychiatric Association (APA) to advance the implementation of measurement-based care (MBC) as well as precision dealing in psychiatry.

Recent Developments:

In August 2021, MindMed announced a collaboration with Florian to advance the development of personalized psychiatry for anxiety disorders. Florian has deep domain experience in RWE and outcomes studies and has developed a variety of information products to serve the healthcare industry.

In May 2024, UAB expanded access to mental health services through advanced practice provider collaborations. They are playing a critical role in meeting the community's overwhelming need for professional, competent, and uniquely compassionate mental health services.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERSONALIZED PSYCHIATRY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GreyBird Ventures

Sunovion Pharmaceuticals Inc.

HMNC Holding GmbH

Arcara Personalized Psychiatry

Starling Minds

Karuna Therapeutics

CBT Plus

AltheaDx, Inc.

WayForward

BrightQuest

Peak Mental Wellness

Others

GLOBAL PERSONALIZED PSYCHIATRY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

• Genomics
• Digital Therapeutics
• Software

GLOBAL PERSONALIZED PSYCHIATRY MARKET, BY THERAPEUTIC AREAS - MARKET ANALYSIS, 2019 - 2032

• Depression and Anxiety
• Bipolar Disorders
• Addiction
• Others

GLOBAL PERSONALIZED PSYCHIATRY MARKET, BY END-USER - MARKET ANALYSIS, 2019 - 2032

• Mental Health Professionals
• Patients
• Healthcare Providers

GLOBAL PERSONALIZED PSYCHIATRY MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

• Sequencing
• Polymerase Chain Reaction
• Microarray
• Immunoassay
• Others

GLOBAL PERSONALIZED PSYCHIATRY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1.Personalized Psychiatry Market Overview

• 1.1.Study Scope
• 1.2.Market Estimation Years

2.Executive Summary

• 2.1.Market Snippet
  • 2.1.1.Personalized Psychiatry Market Snippet by Product Type
  • 2.1.2.Personalized Psychiatry Market Snippet by Therapeutic Areas
  • 2.1.3.Personalized Psychiatry Market Snippet by End User
  • 2.1.4.Personalized Psychiatry Market Snippet by Technology
  • 2.1.5.Personalized Psychiatry Market Snippet by Country
  • 2.1.6.Personalized Psychiatry Market Snippet by Region
• 2.2.Competitive Insights

3.Personalized Psychiatry Key Market Trends

• 3.1.Personalized Psychiatry Market Drivers
  • 3.1.1.Impact Analysis of Market Drivers
• 3.2.Personalized Psychiatry Market Restraints
  • 3.2.1.Impact Analysis of Market Restraints
• 3.3.Personalized Psychiatry Market Opportunities
• 3.4.Personalized Psychiatry Market Future Trends

4.Personalized Psychiatry Industry Study

• 4.1.PEST Analysis
• 4.2.Porter's Five Forces Analysis
• 4.3.Growth Prospect Mapping
• 4.4.Regulatory Framework Analysis

5.Personalized Psychiatry Market: COVID-19 Impact Analysis

• 5.1.Pre-COVID-19 Impact Analysis
• 5.2.Post-COVID-19 Impact Analysis
  • 5.2.1.Top Performing Segments
  • 5.2.2.Marginal Growth Segments
  • 5.2.3.Top Looser Segments
  • 5.2.4.Marginal Loss Segments

6.Personalized Psychiatry Market Landscape

• 6.1.Personalized Psychiatry Market Share Analysis, 2023
• 6.2.Breakdown Data, by Key Manufacturer
  • 6.2.1.Established Players' Analysis
  • 6.2.2.Emerging Players' Analysis

7.Personalized Psychiatry Market - By Product Type

• 7.1.Overview
  • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
  • 7.1.2.Genomics
  • 7.1.3.Digital Therapeutics
  • 7.1.4.Software

8.Personalized Psychiatry Market - By Therapeutic Areas

• 8.1.Overview
  • 8.1.1.Segment Share Analysis, By Therapeutic Areas, 2023 & 2032 (%)
  • 8.1.2.Depression and Anxiety
  • 8.1.3.Bipolar Disorders
  • 8.1.4.Addiction
  • 8.1.5.Others

9.Personalized Psychiatry Market - By End User

• 9.1.Overview
  • 9.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
  • 9.1.2.Mental Health Professionals
  • 9.1.3.Patients
  • 9.1.4.Healthcare Providers

10.Personalized Psychiatry Market - By Technology

• 10.1.Overview
  • 10.1.1.Segment Share Analysis, By Technology, 2023 & 2032 (%)
  • 10.1.2.Sequencing
  • 10.1.3.Polymerase Chain Reaction
  • 10.1.4.Microarray
  • 10.1.5.Immunoassay
  • 10.1.6.Others

11.Personalized Psychiatry Market- By Geography

• 11.1.Introduction
  • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 11.2.North America
  • 11.2.1.Overview
  • 11.2.2.Personalized Psychiatry Key Manufacturers in North America
  • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 11.2.5.North America Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
  • 11.2.6.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.2.7.North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.2.8.U.S.
    • 11.2.8.1.Overview
    • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.8.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.8.4.U.S. Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.2.8.5.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8.6.U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.2.9.Canada
    • 11.2.9.1.Overview
    • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.9.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.9.4.Canada Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.2.9.5.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9.6.Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
• 11.3.Europe
  • 11.3.1.Overview
  • 11.3.2.Personalized Psychiatry Key Manufacturers in Europe
  • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 11.3.5.Europe Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
  • 11.3.6.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.7.Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3.8.Germany
    • 11.3.8.1.Overview
    • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.8.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.8.4.Germany Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.3.8.5.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8.6.Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3.9.Italy
    • 11.3.9.1.Overview
    • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.9.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.9.4.Italy Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.3.9.5.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9.6.Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3.10.United Kingdom
    • 11.3.10.1.Overview
    • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.10.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.10.4.United Kingdom Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.3.10.5.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10.6.United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3.11.France
    • 11.3.11.1.Overview
    • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.11.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.11.4.France Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.3.11.5.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11.6.France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3.12.Russia
    • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.12.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.12.3.Russia Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.3.12.4.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12.5.Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3.13.Netherlands
    • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.13.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.13.3.Netherlands Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.3.13.4.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13.5.Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3.14.Sweden
    • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.14.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.14.3.Sweden Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.3.14.4.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14.5.Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3.15.Poland
    • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.15.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.15.3.Poland Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.3.15.4.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15.5.Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3.16.Rest of Europe
    • 11.3.16.1.Overview
    • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.3.16.5.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16.6.Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
• 11.4.Asia Pacific (APAC)
  • 11.4.1.Overview
  • 11.4.2.Personalized Psychiatry Key Manufacturers in Asia Pacific
  • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 11.4.5.Asia Pacific Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
  • 11.4.6.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.7.Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4.8.India
    • 11.4.8.1.Overview
    • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.8.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.8.4.India Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.4.8.5.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8.6.India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4.9.China
    • 11.4.9.1.Overview
    • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.9.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.9.4.China Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.4.9.5.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9.6.China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4.10.Japan
    • 11.4.10.1.Overview
    • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.10.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.10.4.Japan Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.4.10.5.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10.6.Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4.11.South Korea
    • 11.4.11.1.Overview
    • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.11.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.11.4.South Korea Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.4.11.5.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11.6.South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4.12.Australia
    • 11.4.12.1.Overview
    • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.12.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.12.4.Australia Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.4.12.5.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12.6.Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4.13.Thailand
    • 11.4.13.1.Overview
    • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.13.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.13.4.Thailand Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.4.13.5.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13.6.Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4.14.Indonesia
    • 11.4.14.1.Overview
    • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.14.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.14.4.Indonesia Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.4.14.5.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14.6.Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4.15.Philippines
    • 11.4.15.1.Overview
    • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.15.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.15.4.Philippines Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.4.15.5.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15.6.Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4.16.Rest of APAC
    • 11.4.16.1.Overview
    • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.16.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.16.4.Rest of APAC Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.4.16.5.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16.6.Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
• 11.5.Latin America
  • 11.5.1.Overview
  • 11.5.2.Personalized Psychiatry Key Manufacturers in Latin America
  • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 11.5.5.Latin America Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
  • 11.5.6.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.7.Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.5.8.Brazil
    • 11.5.8.1.Overview
    • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.8.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.8.4.Brazil Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.5.8.5.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8.6.Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.5.9.Mexico
    • 11.5.9.1.Overview
    • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.9.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.9.4.Mexico Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.5.9.5.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9.6.Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.5.10.Argentina
    • 11.5.10.1.Overview
    • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.10.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.10.4.Argentina Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.5.10.5.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10.6.Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.5.11.Colombia
    • 11.5.11.1.Overview
    • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.11.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.11.4.Colombia Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.5.11.5.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11.6.Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.5.12.Rest of LATAM
    • 11.5.12.1.Overview
    • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.5.12.5.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12.6.Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
• 11.6.Middle East and Africa
  • 11.6.1.Overview
  • 11.6.2.Personalized Psychiatry Key Manufacturers in Middle East and Africa
  • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 11.6.5.Middle East and Africa Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
  • 11.6.6.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.7.Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6.8.Saudi Arabia
    • 11.6.8.1.Overview
    • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.6.8.5.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8.6.Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6.9.United Arab Emirates
    • 11.6.9.1.Overview
    • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.6.9.5.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9.6.United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6.10.Israel
    • 11.6.10.1.Overview
    • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.10.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.10.4.Israel Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.6.10.5.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10.6.Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6.11.Turkey
    • 11.6.11.1.Overview
    • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.11.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.11.4.Turkey Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.6.11.5.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11.6.Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6.12.Algeria
    • 11.6.12.1.Overview
    • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.12.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.12.4.Algeria Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.6.12.5.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12.6.Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6.13.Egypt
    • 11.6.13.1.Overview
    • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.13.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.13.4.Egypt Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.6.13.5.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13.6.Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6.14.Rest of MEA
    • 11.6.14.1.Overview
    • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.14.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.14.4.Rest of MEA Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.6.14.5.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14.6.Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Personalized Psychiatry Industry

• 12.1.Competitive Dashboard
• 12.2.Company Profiles
  • 12.2.1.GreyBird Ventures
  • 12.2.2.Sunovion Pharmaceuticals Inc.
  • 12.2.3.HMNC Holding GmbH
  • 12.2.4.Arcara Personalized Psychiatry
  • 12.2.5.Starling Minds
  • 12.2.6.Karuna Therapeutics
  • 12.2.7.CBT Plus
  • 12.2.8.AltheaDx, Inc.
  • 12.2.9.WayForward
  • 12.2.10.BrightQuest
  • 12.2.11.Peak Mental Wellness
  • 12.2.12.Others

13.360 Degree Analyst View

14.Appendix

• 14.1.Research Methodology
• 14.2.References
• 14.3.Abbreviations
• 14.4.Disclaimer
• 14.5.Contact Us